Evogen Expands Executive Team to Launch Affordable, Ultra-Rapid PCR Instrument for High Sensitivity Molecular Diagnostics
Published: Feb 24, 2009
KANSAS CITY, Mo. & WHITE MARSH, Md. & BATH, England--(BUSINESS WIRE)--Evogen Inc. announced today the appointment of two senior executives to its management team to lead the international commercial business efforts for the newly launched EvoCyclerTM HD12 molecular diagnostics platform. This molecular diagnostics and detection instrument provides innovative ultra-rapid PCR amplification and analysis.